In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy

Current therapies against hepatitis B virus (HBV) do not reliably cure chronic infection, necessitating new therapeutic approaches. The T cell response can clear HBV during acute infection, and the adoptive transfer of antiviral T cells during bone marrow transplantation can cure patients of chronic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Methods Clin Dev
Main Authors: Kruse, Robert L., Shum, Thomas, Legras, Xavier, Barzi, Mercedes, Pankowicz, Frank P., Gottschalk, Stephen, Bissig, Karl-Dimiter
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5626922/
https://ncbi.nlm.nih.gov/pubmed/29018834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados